Michael Horowicz | IR and Strategy |
Ugur Sahin | CEO and Co-Founder |
Özlem Türeci | Chief Medical Officer and Co-Founder |
Jens Holstein | CFO |
Ryan Richardson | Chief Strategy Officer |
Tazeen Ahmad | Bank of America |
Daina Graybosch | SVB Securities |
Matthew Harrison | Morgan Stanley |
Yaron Werber | Cowen |
Jessica Fye | JP Morgan |
Good morning and afternoon. Thank you for joining us today for BioNTech’s fourth quarter and full year 2022 earnings call.
As a brief reminder, the slides that accompany this call, and the fourth quarter and full year 2022 press release that was issued this morning can be found in the Investors section of our website.
As outlined on slide 2, you can see our forward-looking statements disclaimer.
Additional information about these statements and other risks are described in our filings made with the U.S.